{"disease":{"id":"postoperative-or-postradiation-adjuvant-androgen-deprivation-therapy-in-locally-advanced-prostate-cancer-high-and-very-high-risk-patients","name":"postoperative or postradiation adjuvant androgen deprivation therapy in locally advanced prostate cancer high and very high risk patients"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02155998","title":"Non-Interventional Study PREVENT","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"AstraZeneca","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}